Imatinib mesylate reduces neurotrophic factors and perk and pakt expression in urinary bladder of female mice with cyclophosphamide-induced cystitis

HIGHLIGHTS

• who: Margaret A. Vizzard from the Department of Neurological Sciences, The Larner College of Medicine, The University of Vermont, Burlington, VT, United States have published the research: Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis, in the Journal: (JOURNAL)
• what: The authors examine the effect of imatinib administration using a prevention design, via oral gavage, or treatment design, via intravesical bladder infusion, on urinary inflammatory mediators and cell signaling kinases in an acute (4 h) CYP-induced cystitis female mouse model, using real . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.